14 contralateral breast cancers were diagnosed in TP53 PV carriers (2 synchronous), 54 in BRCA1 carriers (4 synchronous), and 30 in BRCA2 carriers (2 synchronous), compared to 13 contralateral breast cancers (0 synchronous) among non-carriers. This evidence concerns the gene BRCA2 and breast carcinoma.